JENNIFER BURKE-BRYANT: Open Payments
NPI 1407431729 · LOUISA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$813 in 60 payments from 12 companies in 2025. Trend: 2023 $161 · 2024 $256 · 2025 $813
Food & beverage: $813
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $212 |
| Neurocrine BioSciences, Inc. | 12 | $142 |
| Corium, LLC | 7 | $97 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Alkermes, Inc. | 3 | $48 |
| Sage Therapeutics, LLC | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $28 |
Products named: VRAYLAR, INGREZZA, Azstarys, Auvelity, REXULTI, LYBALVI, ZURZUVAE, COBENFY.
Industry payments across KY — which companies pay providers there.
